Developing a vaccine to protect against HIV
Induction of protective antibodies for HIV vaccine development
This study is working on a new HIV vaccine that aims to help your body fight the virus better by creating special antibodies, and it's designed for people everywhere who want to protect themselves from HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10877768 on NIH RePORTER |
What this research studies
This research focuses on creating an effective vaccine for HIV by using advanced technologies and immunologic tools. The project aims to induce protective antibodies that can neutralize the virus and enhance the immune response. Researchers will explore two main strategies: one to generate broadly neutralizing antibodies and another to produce protective non-neutralizing antibodies. The ultimate goal is to develop a vaccine that can be used globally to combat HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for HIV infection or those interested in participating in vaccine trials.
Not a fit: Patients who are already HIV-positive or those with severe immune system deficiencies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a safe and effective vaccine that protects individuals from HIV infection.
How similar studies have performed: Previous research in HIV vaccine development has shown promise, but this approach aims to build on those findings with innovative strategies.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Haynes, Barton F. — Duke University
- Study coordinator: Haynes, Barton F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.